OBJECTIVES: Total blood homocysteine (Hcys) and folate levels have been investigated in association with cognitive dysfunction in healthy but not in multimorbid elderly patients. We hypothesized that total serum Hcys is an adequate marker to identify multimorbid elderly patients with cognitive dysfunction assessed by the Short Cognitive Performance Test (SKT) and Mini-Mental State Examination (MMSE). DESIGN: Cross-sectional study. SETTING: The study center was an acute geriatric hospital. PARTICIPANTS: A total of 189 multimorbid elderly patients were recruited. METHODS: Cognitive dysfunction was determined according to the SKT and MMSE. Biochemical parameters (Hcys, folate, vitamin B12, hemoglobin), nutritional status (BMI, Mini Nutritional Assessment, nutritional intake), and activities of daily living were assessed. RESULTS: According to the SKT, 25.4% of patients showed no cerebral cognitive dysfunction, 21.2% had suspected incipient cognitive dysfunction, 12.7% showed mild cognitive dysfunction, 9.0% had moderate cognitive dysfunction, and 31.7% of patients were demented. The median plasma Hcys value was elevated by approximately 20% in multimorbid elderly patients, independent of cognitive dysfunction. Serum folate and vitamin B12 concentrations were within normal ranges. We did not find significant differences in nutritional status, activities of daily living, numbers of diseases or medications, or selected biochemical parameters between the SKT groups. CONCLUSION: Elevated serum Hcys levels with normal plasma folate and vitamin B12 concentrations were observed in multimorbid elderly patients. The plasma Hcys level did not appear to be an important biological risk factor for cognitive dysfunction in multimorbid geriatric patients.
OBJECTIVES:Total blood homocysteine (Hcys) and folate levels have been investigated in association with cognitive dysfunction in healthy but not in multimorbid elderly patients. We hypothesized that total serum Hcys is an adequate marker to identify multimorbid elderly patients with cognitive dysfunction assessed by the Short Cognitive Performance Test (SKT) and Mini-Mental State Examination (MMSE). DESIGN: Cross-sectional study. SETTING: The study center was an acute geriatric hospital. PARTICIPANTS: A total of 189 multimorbid elderly patients were recruited. METHODS:Cognitive dysfunction was determined according to the SKT and MMSE. Biochemical parameters (Hcys, folate, vitamin B12, hemoglobin), nutritional status (BMI, Mini Nutritional Assessment, nutritional intake), and activities of daily living were assessed. RESULTS: According to the SKT, 25.4% of patients showed no cerebral cognitive dysfunction, 21.2% had suspected incipient cognitive dysfunction, 12.7% showed mild cognitive dysfunction, 9.0% had moderate cognitive dysfunction, and 31.7% of patients were demented. The median plasma Hcys value was elevated by approximately 20% in multimorbid elderly patients, independent of cognitive dysfunction. Serum folate and vitamin B12 concentrations were within normal ranges. We did not find significant differences in nutritional status, activities of daily living, numbers of diseases or medications, or selected biochemical parameters between the SKT groups. CONCLUSION: Elevated serum Hcys levels with normal plasma folate and vitamin B12 concentrations were observed in multimorbid elderly patients. The plasma Hcys level did not appear to be an important biological risk factor for cognitive dysfunction in multimorbid geriatric patients.
Authors: J Lindenbaum; E B Healton; D G Savage; J C Brust; T J Garrett; E R Podell; P D Marcell; S P Stabler; R H Allen Journal: Nutrition Date: 1995 Mar-Apr Impact factor: 4.008
Authors: J Metz; A H Bell; L Flicker; T Bottiglieri; J Ibrahim; E Seal; D Schultz; H Savoia; K M McGrath Journal: J Am Geriatr Soc Date: 1996-11 Impact factor: 5.562
Authors: Andrea Strassburg; Carolin Krems; Petra M Lührmann; Bernd Hartmann; Monika Neuhäuser-Berthold Journal: Int J Vitam Nutr Res Date: 2004-03 Impact factor: 1.784
Authors: C E Teunissen; A Henk J Blom; M P J Van Boxtel; H Bosma; C de Bruijn; J Jolles; B A Wauters; H W M Steinbusch; J de Vente Journal: J Nutr Health Aging Date: 2003 Impact factor: 4.075